Your browser doesn't support javascript.
loading
The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021-December 2022.
Fiebelkorn, Amy Parker; Adelsberg, Sara; Anthony, Rishelle; Ashenafi, Samrawit; Asif, Amimah F; Azzarelli, Maria; Bailey, Theresa; Boddie, Timothy Tee; Boyer, Alaina P; Bungum, Nicole Williams; Burstin, Helen; Burton, Jacqueline L; Casey, David M; Chaumont Menendez, Cammie; Courtot, Brigette; Cronin, Kelly; Dowdell, Cherrie; Downey, Laura H; Fields, Megan; Fitzsimmons, Tom; Frank, Alexa; Gustafson, Emily; Gutierrez-Nkomo, Margaret; Harris, Benita L; Hill, Joanna; Holmes, Kathleen; Huerta Migus, Laura; Jacob Kuttothara, Joanna; Johns, Natalie; Johnson, Jennifer; Kelsey, Alice; Kingangi, Lucy; Landrum, Cynthia M; Lee, James T; Martinez, Pedro D; Medina Martínez, Gisela; Nicholls, Richard; Nilson, Jane R; Ohiaeri, Nma; Pegram, Laura; Perkins, Claire; Piasecki, Alexandra M; Pindyck, Talia; Price, Sarah; Rodgers, Michelle S; Roney, Heather; Schultz, Ellen M; Sobczyk, Elizabeth; Thierry, JoAnn M; Toledo, Chelsea.
Afiliação
  • Fiebelkorn AP; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Electronic address: AFiebelkorn@cdc.gov.
  • Adelsberg S; Deloitte Consulting, LLP, NY City, NY, USA.
  • Anthony R; Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), CDC, Atlanta, GA, USA.
  • Ashenafi S; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Asif AF; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Azzarelli M; Southern Nevada Health District, Las Vegas, Nevada, USA.
  • Bailey T; Deloitte Consulting, LLP, NY City, NY, USA.
  • Boddie TT; Conference of National Black Churches, Atlanta, GA, USA.
  • Boyer AP; National Health Care for the Homeless Council, Nashville, TN, USA.
  • Bungum NW; Southern Nevada Health District, Las Vegas, Nevada, USA.
  • Burstin H; Council of Medical Specialty Societies, Washington DC, USA.
  • Burton JL; Conference of National Black Churches, Atlanta, GA, USA.
  • Casey DM; AMDA - The Society for Post-Acute and Long-Term Care Medicine, Inc, Columbia, MD, USA.
  • Chaumont Menendez C; Division of Safety Research, National Institute for Occupational Safety and Health, CDC, Morgantown, WV, USA.
  • Courtot B; The Urban Institute, Washington DC, USA.
  • Cronin K; Administration for Community Living, Washington DC, USA.
  • Dowdell C; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Downey LH; U.S. Cooperative Extension System, Extension Committee on Organization and Policy, United States Department of Agriculture (USDA), Washington DC, USA.
  • Fields M; CDC Foundation, Atlanta, GA, USA.
  • Fitzsimmons T; American Hospital Association, Health Research and Educational Trust, Chicago, IL, USA.
  • Frank A; Deloitte Consulting, LLP, NY City, NY, USA.
  • Gustafson E; American Hospital Association, Health Research and Educational Trust, Chicago, IL, USA.
  • Gutierrez-Nkomo M; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Harris BL; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Hill J; ASRT, Inc., Smyrna, GA, USA.
  • Holmes K; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Huerta Migus L; Institute of Museum and Library Services, Washington DC, USA.
  • Jacob Kuttothara J; UnidosUS, Washington DC, USA.
  • Johns N; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Johnson J; Administration for Community Living, Washington DC, USA.
  • Kelsey A; Administration for Community Living, Washington DC, USA.
  • Kingangi L; Oak Ridge Associated Universities (ORAU), Oakridge, TN, USA; Goldbelt C6, LLC, Juneau, AK, USA.
  • Landrum CM; Institute of Museum and Library Services, Washington DC, USA.
  • Lee JT; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Martinez PD; UnidosUS, Washington DC, USA.
  • Medina Martínez G; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Nicholls R; Administration for Community Living, Washington DC, USA.
  • Nilson JR; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Ohiaeri N; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Pegram L; NASTAD, Washington DC, USA.
  • Perkins C; Deloitte Consulting, LLP, NY City, NY, USA.
  • Piasecki AM; Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Pindyck T; Division of Viral Hepatitis, NCHHSTP, CDC, Atlanta, GA, USA.
  • Price S; National Association of Community Health Centers, Bethesda, MD, USA.
  • Rodgers MS; U.S. Cooperative Extension System, Extension Committee on Organization and Policy, United States Department of Agriculture (USDA), Washington DC, USA.
  • Roney H; AMDA - The Society for Post-Acute and Long-Term Care Medicine, Inc, Columbia, MD, USA.
  • Schultz EM; AMDA - The Society for Post-Acute and Long-Term Care Medicine, Inc, Columbia, MD, USA.
  • Sobczyk E; AMDA - The Society for Post-Acute and Long-Term Care Medicine, Inc, Columbia, MD, USA.
  • Thierry JM; Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, GA, USA.
  • Toledo C; Global Immunization Division, Global Health Center, CDC, Atlanta, GA, USA.
Vaccine ; 2024 Jan 17.
Article em En | MEDLINE | ID: mdl-38238113
ABSTRACT
During the COVID-19 vaccination rollout from March 2021- December 2022, the Centers for Disease Control and Prevention funded 110 primary and 1051 subrecipient partners at the national, state, local, and community-based level to improve COVID-19 vaccination access, confidence, demand, delivery, and equity in the United States. The partners implemented evidence-based strategies among racial and ethnic minority populations, rural populations, older adults, people with disabilities, people with chronic illness, people experiencing homelessness, and other groups disproportionately impacted by COVID-19. CDC also expanded existing partnerships with healthcare professional societies and other core public health partners, as well as developed innovative partnerships with organizations new to vaccination, including museums and libraries. Partners brought COVID-19 vaccine education into farm fields, local fairs, churches, community centers, barber and beauty shops, and, when possible, partnered with local healthcare providers to administer COVID-19 vaccines. Inclusive, hyper-localized outreach through partnerships with community-based organizations, faith-based organizations, vaccination providers, and local health departments was critical to increasing COVID-19 vaccine access and building a broad network of trusted messengers that promoted vaccine confidence. Data from monthly and quarterly REDCap reports and monthly partner calls showed that through these partnerships, more than 295,000 community-level spokespersons were trained as trusted messengers and more than 2.1 million COVID-19 vaccinations were administered at new or existing vaccination sites. More than 535,035 healthcare personnel were reached through outreach strategies. Quality improvement interventions were implemented in healthcare systems, long-term care settings, and community health centers resulting in changes to the clinical workflow to incorporate COVID-19 vaccine assessments, recommendations, and administration or referrals into routine office visits. Funded partners' activities improved COVID-19 vaccine access and addressed community concerns among racial and ethnic minority groups, as well as among people with barriers to vaccination due to chronic illness or disability, older age, lower income, or other factors.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Vaccine Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Vaccine Ano de publicação: 2024 Tipo de documento: Article